5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC
Condition(s):Squamous Cell Carcinoma of Head and NeckLast Updated:October 19, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Squamous Cell Carcinoma of Head and NeckLast Updated:October 19, 2023Recruiting
Condition(s):Myelodysplastic Syndrome; ChemotherapyLast Updated:December 8, 2017Unknown status
Condition(s):Non-Small Cell Lung Cancer; Epigenetic TherapyLast Updated:June 7, 2023Completed
Condition(s):Leukemia, Myeloid, AcuteLast Updated:January 14, 2021Completed
Condition(s):Myelodysplastic Syndromes; Acute Myelogenous LeukemiaLast Updated:December 18, 2013Terminated
Condition(s):Adult Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Acute Myeloid LeukemiaLast Updated:October 2, 2023Active, not recruiting
Condition(s):Stage IA Non-Small Cell Lung Carcinoma; Stage IB Non-Small Cell Lung CarcinomaLast Updated:February 5, 2019Terminated
Condition(s):Leukemia, Acute Myeloid (AML)Last Updated:March 23, 2023Recruiting
Condition(s):Diffuse Large B Cell LymphomaLast Updated:March 24, 2023Recruiting
Condition(s):Acute Myeloid Leukemia, in Relapsed or Refractory; Acute Myeloid Leukemia, Elderly, Unfit; Acute Myeloid Leukemia With Positive Minimal Residual DiseaseLast Updated:September 9, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.